Epidemiology of NSAID-induced gastropathy
- PMID: 1802489
- DOI: 10.1007/BF02206654
Epidemiology of NSAID-induced gastropathy
Similar articles
-
Epidemiology and NSAID induced gastropathy.J Rheumatol Suppl. 1991 Mar;28:2-5. J Rheumatol Suppl. 1991. PMID: 2038013
-
Practical management of NSAID gastropathy in rheumatic patients.Scand J Rheumatol Suppl. 1989;78:12-7; discussion 30-2. doi: 10.3109/03009748909101458. Scand J Rheumatol Suppl. 1989. PMID: 2786645
-
The management of NSAID gastropathy.Baillieres Clin Rheumatol. 1990 Aug;4(2):269-91. doi: 10.1016/s0950-3579(05)80021-4. Baillieres Clin Rheumatol. 1990. PMID: 2032300 Review. No abstract available.
-
Nonsteroidal anti-inflammatory drug-induced gastric damage: epidemiology.Dig Dis. 1995 Jan;13 Suppl 1:3-8. doi: 10.1159/000171522. Dig Dis. 1995. PMID: 7697900 Review.
-
Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice.Ann Intern Med. 1988 Sep 1;109(5):353-4. doi: 10.7326/0003-4819-109-5-353. Ann Intern Med. 1988. PMID: 3044208 Review. No abstract available.
Cited by
-
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs.Pharmacoeconomics. 2001;19(7):779-90. doi: 10.2165/00019053-200119070-00006. Pharmacoeconomics. 2001. PMID: 11548913
-
Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.Pharmacoeconomics. 1999 Jul;16(1):85-98. doi: 10.2165/00019053-199916010-00008. Pharmacoeconomics. 1999. PMID: 10539124 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical